This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Belli, W. A.
Right arrow Articles by Fryklund, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Belli, W. A.
Right arrow Articles by Fryklund, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, Aug 1995, 1717-1720, Vol 39, No. 8
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Partial characterization and effect of omeprazole on ATPase activity in Helicobacter pylori by using permeabilized cells

WA Belli and J Fryklund
Department of Cell Biology, Preclinical Research and Development, Astra Hassle AB, Molndal, Sweden.

ATPase activity in permeabilized cells of Helicobacter pylori as well as those of Helicobacter felis and Campylobacter jejuni was analyzed. The ATPase activities in these cells were most susceptible to sodium azide, fluoroaluminate, and dicyclohexylcarbodiimide, which are typical inhibitors of F ATPases. Optimal values for maximal activity were found to be at approximately pH 6.4, 6.0, and 6.0 for C. jejuni, H. pylori, and H. felis, respectively. The substituted benzimidazole compounds omeprazole, lansoprazole, and Eisai 3810 were found to have no effect on the F ATPase activity of H. pylori at concentrations which are inhibitory for cell growth (MICs). In addition, an extracellular, vanadate-susceptible ATPase activity was detected in H. pylori, which was also relatively insusceptible to the benzimidazole compounds. Thus, the mechanism of killing mediated by omeprazole and related compounds in Helicobacter pylori does not appear to be due to diminished ATPase activity.


This article has been cited by other articles:

  • Barak, Y., Ackerley, D. F., Dodge, C. J., Banwari, L., Alex, C., Francis, A. J., Matin, A. (2006). Analysis of novel soluble chromate and uranyl reductases and generation of an improved enzyme by directed evolution.. Appl. Environ. Microbiol. 72: 7074-7082 [Abstract] [Full Text]  
  • Sutak, R., Tachezy, J., Kulda, J., Hrdy, I. (2004). Pyruvate Decarboxylase, the Target for Omeprazole in Metronidazole-Resistant and Iron-Restricted Tritrichomonas foetus. Antimicrob. Agents Chemother. 48: 2185-2189 [Abstract] [Full Text]  
  • Nagata, K., Sone, N., Tamura, T. (2001). Inhibitory Activities of Lansoprazole against Respiration in Helicobacter pylori. Antimicrob. Agents Chemother. 45: 1522-1527 [Abstract] [Full Text]